Aligos Therapeutics (ALGS) Current Assets (2021 - 2025)
Historic Current Assets for Aligos Therapeutics (ALGS) over the last 5 years, with Q3 2025 value amounting to $103.4 million.
- Aligos Therapeutics' Current Assets rose 2958.21% to $103.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $103.4 million, marking a year-over-year increase of 2958.21%. This contributed to the annual value of $62.1 million for FY2024, which is 5595.46% down from last year.
- Latest data reveals that Aligos Therapeutics reported Current Assets of $103.4 million as of Q3 2025, which was up 2958.21% from $127.9 million recorded in Q2 2025.
- Over the past 5 years, Aligos Therapeutics' Current Assets peaked at $248.7 million during Q3 2021, and registered a low of $62.1 million during Q4 2024.
- Over the past 5 years, Aligos Therapeutics' median Current Assets value was $133.5 million (recorded in 2022), while the average stood at $140.5 million.
- Per our database at Business Quant, Aligos Therapeutics' Current Assets tumbled by 5595.46% in 2024 and then skyrocketed by 2958.21% in 2025.
- Aligos Therapeutics' Current Assets (Quarter) stood at $204.4 million in 2021, then tumbled by 34.67% to $133.5 million in 2022, then grew by 5.65% to $141.1 million in 2023, then plummeted by 55.95% to $62.1 million in 2024, then soared by 66.45% to $103.4 million in 2025.
- Its Current Assets stands at $103.4 million for Q3 2025, versus $127.9 million for Q2 2025 and $143.2 million for Q1 2025.